You are here:

Home
NICE Guidance
Conditions and diseases
Musculoskeletal conditions
Arthritis

Golimumab for the treatment of rheumatoid arthritis after the failure of previous disease-modifying anti-rheumatic drugs

Technology appraisal guidance
Reference number: TA225
Published: 22 June 2011

Guidance
Tools and resources
Information for the public
History

Patient Access Scheme

Patient Access Scheme submitted by Merck Sharpe & Dohme (MSD)
Letter from the Department of Health confirming NICE can consider the Patient Access Scheme

This page was last updated: 12 May 2011